Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Anna Wojcicki Gamble, M.D.

Concepts (33)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Anna Wojcicki Gamble's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Anna Wojcicki Gamble has written about over time.
Afibrinogenemia, 1 publications between 2016 and 2016, average publication date December 2016. Fibrin, 1 publications between 2016 and 2016, average publication date December 2016. Fibrinogen, 1 publications between 2016 and 2016, average publication date December 2016. Macrophage-1 Antigen, 1 publications between 2016 and 2016, average publication date December 2016. Matrix Metalloproteinase 12, 1 publications between 2016 and 2016, average publication date December 2016. Leukemia, Myeloid, Acute, 1 publications between 2020 and 2020, average publication date May 2020. Metabolome, 1 publications between 2020 and 2020, average publication date May 2020. Ulcer, 1 publications between 2021 and 2021, average publication date October 2021. Vaccination, 1 publications between 2021 and 2021, average publication date October 2021. Vulvar Diseases, 1 publications between 2021 and 2021, average publication date October 2021. Adoption, 1 publications between 2023 and 2023, average publication date February 2023. Haiti, 1 publications between 2023 and 2023, average publication date February 2023. Hepatitis B, 1 publications between 2023 and 2023, average publication date February 2023. Lead, 1 publications between 2023 and 2023, average publication date February 2023.

To see the data from this visualization as text, click here.
Wojcicki Gamble's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (33)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.